To evaluate the therapeutic response to uterine artery embolization in 30 patients with leiomyoma using the microspheres Embosoft (Embosoft® - Scitech Medical).

Inclusion Criteria:

• female patients from 18 to 50 years old;
• symptomatic uterine intramural leiomyomas or multiple symptomatic leiomyomas in the presence of intramural;
• patient agrees with study procedures;
• patient signs the informed consent form.

Exclusion Criteria:

• asymptomatic women;
• isolated adenomyosis, pediculated subserous myoma, submucous leiomyoma (50% of uterine cavity diameter), intraligamentous leiomyoma;
• leiomyoma diameter higher than 10 cm;
• leiomyoma above the umbilical scar;
• endometrial neoplasia or hyperplasia or presence of any malignancy
• pregnant or breast feeding women;
• active vasculitis;
• pelvic irradiation history;
• uncontrolled coagulopathies;
• renal insufficiency;
• contrast allergy;
• concomitant use of GnRH analogues.

Female patients with Uterine Leiomyoma